Published in Clin Cancer Res on September 08, 2016
Hallmarks of cancer: the next generation. Cell (2011) 140.01
TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 10.20
Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med (2007) 6.84
Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science (2011) 5.72
Chemical remodelling of cell surfaces in living animals. Nature (2004) 4.86
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res (2008) 4.79
Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med (2013) 4.23
Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med (2011) 4.08
MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A (2007) 3.97
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res (2005) 3.71
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med (2001) 3.24
Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer (2013) 3.23
In vivo imaging of glucose uptake and metabolism in tumors. Nat Med (2013) 3.01
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci U S A (2013) 2.57
New approaches for imaging tumour responses to treatment. Nat Rev Cancer (2008) 2.38
Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol (2015) 2.35
Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A (2009) 2.04
Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer (2015) 2.00
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell (2014) 1.90
Metabolic Heterogeneity in Human Lung Tumors. Cell (2016) 1.86
Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Nat Med (2012) 1.83
Acetate dependence of tumors. Cell (2014) 1.80
Tumor cell metabolism imaging. J Nucl Med (2008) 1.67
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model. Gut (2015) 1.51
Hyperpolarized [1-13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo. J Am Chem Soc (2011) 1.47
The clinical use of PET with (11)C-acetate. Am J Nucl Med Mol Imaging (2011) 1.43
Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. Chem Soc Rev (2013) 1.41
Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose. Nat Med (2013) 1.35
Metabolic imaging in the anesthetized rat brain using hyperpolarized [1-13C] pyruvate and [1-13C] ethyl pyruvate. Magn Reson Med (2010) 1.34
Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am (2010) 1.31
31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27
Non-invasive in vivo assessment of IDH1 mutational status in glioma. Nat Commun (2013) 1.26
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Sci Transl Med (2015) 1.23
Hyperpolarized magnetic resonance as a sensitive detector of metabolic function. Biochemistry (2014) 1.20
Boosting Dissolution Dynamic Nuclear Polarization by Cross Polarization. J Phys Chem Lett (2012) 1.18
Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med (2014) 1.15
Imaging metabolism with hyperpolarized (13)C-labeled cell substrates. J Am Chem Soc (2015) 1.08
Dynamic nuclear polarization at 700 MHz/460 GHz. J Magn Reson (2012) 1.07
Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. J Biol Chem (2009) 1.06
Imaging sialylated tumor cell glycans in vivo. FASEB J (2011) 1.05
Automated transfer and injection of hyperpolarized molecules with polarization measurement prior to in vivo NMR. NMR Biomed (2013) 1.05
Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol (2015) 1.03
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling. Cell Rep (2016) 1.03
Investigating tumor perfusion and metabolism using multiple hyperpolarized (13)C compounds: HP001, pyruvate and urea. Magn Reson Imaging (2011) 1.02
Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast. Brain Dev (2015) 1.02
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol (2015) 0.99
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol (2016) 0.98
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. Clin Cancer Res (2015) 0.96
Imaging cell surface glycosylation in vivo using "double click" chemistry. Bioconjug Chem (2013) 0.94
Non-invasive in-cell determination of free cytosolic [NAD+]/[NADH] ratios using hyperpolarized glucose show large variations in metabolic phenotypes. J Biol Chem (2013) 0.92
Combined PET/MR: a technology becomes mature. J Nucl Med (2015) 0.89
Hyperpolarized butyrate: a metabolic probe of short chain fatty acid metabolism in the heart. Magn Reson Med (2013) 0.89
Hyperpolarized [1,3-13C2 ]ethyl acetoacetate is a novel diagnostic metabolic marker of liver cancer. Int J Cancer (2014) 0.87
Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer. Q J Nucl Med Mol Imaging (2012) 0.87
In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamine. J Magn Reson (2013) 0.86
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy. Br J Cancer (2009) 0.86
Mapping of prostate cancer by 1H MRSI. NMR Biomed (2013) 0.85
In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma. Clin Cancer Res (2015) 0.81
Lactate Chemical Exchange Saturation Transfer (LATEST) Imaging in vivo A Biomarker for LDH Activity. Sci Rep (2016) 0.81
Evidence-based indications for the use of PET-CT in the United Kingdom 2016. Clin Radiol (2016) 0.81
Potential Clinical Roles for Metabolic Imaging with Hyperpolarized [1-(13)C]Pyruvate. Front Oncol (2016) 0.80
Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer. J Nucl Med (2015) 0.79
Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver. Proc Natl Acad Sci U S A (2014) 0.79
A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes. J Nucl Med (2015) 0.79
In vivo (1) H MRSI of glycine in brain tumors at 3T. Magn Reson Med (2015) 0.78
Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging. Angew Chem Int Ed Engl (2015) 0.78
PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2. Sci Transl Med (2015) 0.78
Imaging tumor metabolism using positron emission tomography. Cancer J (2015) 0.78
Increase of signal-to-noise of more than 10,000 times in liquid state NMR. Discov Med (2003) 0.78
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis. Eur J Nucl Med Mol Imaging (2016) 0.78
Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas. Cancer Res (2015) 0.76
(13) C MRS of human brain at 7 Tesla using [2-(13) C]glucose infusion and low power broadband stochastic proton decoupling. Magn Reson Med (2015) 0.76